Episode Details

Explore the evolving landscape of traditional Chinese medicine as a major industry leader undergoes a strategic transformation. We dive into Tianjin Pharmaceutical Da Ren Tang's internal restructuring, high-stakes asset disposals, and a bold new brand-led vision aiming to redefine the company's future in a shifting market.

• The strategic move to deconsolidate key business units and its impact on the corporate structure

• Unpacking the final exit from a long-standing international joint venture

• How the "preventive healthcare" philosophy is driving innovation and research in the pharmaceutical sector